Among the 218 patients who could be evaluated , pregnancy occurred in more women in the goserelin group than in the chemotherapy-alone group ( 21 % vs. 11 % , P = 0.03 ) ; women in the goserelin group also had improved disease-free survival ( P = 0.04 ) and overall survival ( P = 0.05 ) .